Centene Corporation (NYSE: CNC) (“Centene”) and WellCare Health Plans, Inc. (NYSE: WCG) (“WellCare”) today announced that leading independent proxy advisory firm Institutional Shareholder Services (“ISS”) recommends that Centene and WellCare stockholders vote “FOR” all transaction-related proposals at the respective special meetings of stockholders regarding Centene’s pending acquisition of WellCare.
As previously announced, the Centene Special Meeting of stockholders to vote on the shares of Centene common stock to be issued in connection with the transaction is scheduled to take place on June 24, 2019, at 10 a.m. Central
Time and will be held at Centene Plaza, 7700 Forsyth Boulevard, St. Louis, Missouri. All stockholders of record of Centene common stock as of the close of business on May 8, 2019, will be entitled to vote their shares either in person or by proxy at the Special Meeting.
The WellCare Special Meeting of stockholders to vote on the transaction is scheduled to take place on June 24, 2019, at 11 a.m. Eastern Time and will be held at the offices of Kirkland & Ellis LLP, 601 Lexington Avenue, New York, New York 10022. All stockholders of record of WellCare common stock as of the close of business on May 22, 2019, will be entitled to vote their shares either in person or by proxy at the Special Meeting.
Centene stockholders who need assistance in completing the proxy card, need additional copies of the proxy materials, or have questions regarding the Centene Special Meeting may contact Centene’s proxy solicitors:
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Morrow Sodali, LLC
(800) 662-5200 (toll-free)
(203) 658-9400 (collect)
Email: cnc@morrowsodali.com
or
Saratoga Proxy Consulting LLC
(888) 368-0379 (toll-free)
(212) 257-1311 (collect)
Email: info@saratogaproxy.com
WellCare stockholders who need assistance in completing the proxy card, need
additional copies of the proxy materials, or have questions regarding the
WellCare Special Meeting may contact WellCare’s proxy solicitor:
Innisfree M&A Incorporated
(888) 750-5834 (toll-free)
(212) 750-5833 (collect)
Date: June 17, 2019
Source: Bloomberg